ProShare Advisors’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-16,195
Closed -$339K 1915
2022
Q3
$339K Sell
16,195
-409
-2% -$8.52K ﹤0.01% 1074
2022
Q2
$345K Sell
16,604
-8,767
-35% -$156K ﹤0.01% 1136
2022
Q1
$426K Sell
25,371
-3,077
-11% -$53.8K ﹤0.01% 1386
2021
Q4
$568K Buy
28,448
+10,064
+55% +$189K ﹤0.01% 1357
2021
Q3
$333K Sell
18,384
-14,798
-45% -$339K ﹤0.01% 1476
2021
Q2
$896K Sell
33,182
-2,695
-8% -$75.4K ﹤0.01% 1103
2021
Q1
$1.07M Buy
35,877
+6,393
+22% +$218K ﹤0.01% 941
2020
Q4
$847K Buy
29,484
+13,923
+89% +$376K ﹤0.01% 958
2020
Q3
$380K Sell
15,561
-1,058
-6% -$22.8K ﹤0.01% 1055
2020
Q2
$297K Buy
+16,619
New +$218K ﹤0.01% 1233
2019
Q3
Sell
-9,967
Closed -$244K 1703
2019
Q2
$244K Sell
9,967
-1,777
-15% -$51.2K ﹤0.01% 1339
2019
Q1
$374K Buy
+11,744
New +$417K ﹤0.01% 1156

Other funds holding CVET

ProShare Advisors's CVET Position: Q4 2022 in Review

ProShare Advisors sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 16,195 shares — an estimated $339K sold.

ProShare Advisors first reported a position in CVET in Q1 2019 and held it in 12 quarters. The position peaked at $1.07M in Q1 2021. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • ProShare Advisors reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • ProShare Advisors sold 16,195 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $339K.
  • ProShare Advisors first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 12 quarters.
  • ProShare Advisors's Covetrus, Inc. Common Stock position peaked at $1.07M in Q1 2021.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on ProShare Advisors's 13F filing for Q4 2022, filed 2 Feb 2023.